**Core Concept**
The question is testing the student's knowledge of **pheochromocytoma**, a rare tumor of the adrenal gland, and its potential for malignancy. **Pheochromocytomas** are catecholamine-secreting neuroendocrine tumors that can be benign or malignant. The distinction between benign and malignant pheochromocytoma is crucial for management and prognosis.

**Why the Correct Answer is Right**
Unfortunately, without the answer choices, it's challenging to provide a detailed explanation. However, in general, malignancy in pheochromocytoma is often indicated by the presence of **metastasis**, which is the spread of cancer cells to other parts of the body. Other indicators may include **tumor size**, **invasion** of surrounding tissues, and **genetic mutations**.

**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific option, it's difficult to provide a detailed explanation. However, if Option A referred to a benign characteristic, it would be incorrect because it doesn't indicate malignancy.
**Option B:** Similarly, without the specific option, it's challenging to provide a detailed explanation. If Option B referred to a non-specific symptom, it would be incorrect because it's not a definitive indicator of malignancy.
**Option C:** Again, without the specific option, it's difficult to provide a detailed explanation. If Option C referred to a characteristic that is not unique to malignant pheochromocytoma, it would be incorrect.
**Option D:** If Option D is the correct answer, the other options would be incorrect because they do not accurately indicate malignancy in pheochromocytoma.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that **malignant pheochromocytomas** are often diagnosed retrospectively, after metastasis has occurred. The presence of **metastasis** is a definitive indicator of malignancy.

**Correct Answer:** Unfortunately, without the answer choices, it's impossible to provide the correct answer.